High-Throughput,Cell-Free,Liposome-Based Approach for Assessing In Vitro Activity of Lipid Kinases

Abstract

Lipid kinases are central players in lipid signaling pathways involved in inflammation, tumorigenesis, and metabolic syndrome. A number of these kinase targets have proven difficult to investigate in higher throughput cell-free assay systems. This challenge is partially due to specific substrate interaction requirements for several of the lipid kinase family members and the resulting incompatibility of these substrates with most established, homogeneous assay formats. Traditional, cell-free in vitro investigational methods for members of the lipid kinase family typically involve substrate incorporation of [γ-³²P] and resolution of signal by thin-layer chromatography (TLC) and autoradiograph densitometry. This approach, although highly sensitive, does not lend itself to high-throughput testing of large numbers of small molecules (100 s to 1 MM+). The authors present the development and implementation of a fully synthetic, liposome-based assay for assessing in vitro activity of phosphatidylinositol-5-phosphate-4-kinase isoforms (PIP4KIIβ and α) in 2 commonly used homogeneous technologies. They have validated these assays through compound testing in both traditional TLC and radioactive filterplate approaches as well as binding validation using isothermic calorimetry. A directed library representing known kinase pharmacophores was screened against type IIβ phosphatidylinositol-phosphate kinase (PIPK) to identify small-molecule inhibitors. This assay system can be applied to other types and isoforms of PIPKs as well as a variety of other lipid kinase targets. (Journal of Biomolecular Screening 2009:838-844)

Keywords

lipid kinase PIP4KIIβ liposome luminescence fluorescent polarization

References

Wymann MP , Schneiter R. : Lipid signalling in disease. Nat Rev Mol Cell Biol 2008;9:162-176.

Manning BD , Cantley LC : AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-1274.

Munagala N. , Nguyen S. , Lam W. , Lee J. , Joly A. , McMillan K. , et al: Identification of small molecule ceramide kinase inhibitors using a homogeneous chemiluminescence high throughput assay. Assay Drug Dev Technol 2007;5:65-74.

Minogue S. , Waugh MG , De Matteis MA , Stephens DJ , Berditchevski F. , Hsuan JJ : Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. J Cell Sci 2006;119: 571-581.

Halstead JR , Jalink K. , Divecha N. : An emerging role for PtdIns(4,5) P2-mediated signalling in human disease. Trends Pharmacol Sci 2005; 26:654-660.

Whiteford CC , Brearley CA , Ulug ET : Phosphatidylinositol 3,5-bisphosphate defines a novel PI 3-kinase pathway in resting mouse fibroblasts . Biochem J 1997;323:597-601.

Carricaburu V. , Lamia KA , Lo E. , Favereaux L. , Payrastre B. , Cantley LC , et al: The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Proc Natl Acad Sci 2003;100:9867-9872.

Lamia KA , Peroni OD , Kim YB , Rameh LE , Kahn BB , Cantley LC : Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase β-/- mice. Mol Cell Biol 2004;24:5080-5087.

Don AS , Rosen H. : A fluorescent plate reader assay for ceramide kinase. Anal Biochem 2008;375:265-271.

10.

Tolias KF , Rameh LE , Ishihara H. , Shibasaki Y. , Chen J. , Prestwich GD , et al: Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. J Biol Chem 1998;273:18040-18046.

11.

Fuchikami K. , Togame H. , Sagara A. , Satoh T. , Gantner F. , Bacon KB , et al: A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma . J Biomol Screen 2002;7:441-450.

12.

Burden LM , Rao VD , Murray D. , Ghirlando R. , Doughman SD , Anderson RA , et al: The flattened face of type IIβ: phosphatidylinositol phosphate kinase binds acidic phospholipid membranes. Biochemistry 1999;38: 15141-15149.

13.

Zhang JH , Chung TDY , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.

14.

Klink TA , Kleman-Leyer KM , Kopp A. , Westermeyer TA , Lowery RG : Evaluating PI3 kinase isoforms using Transcreener™ ADP assay . J Biomol Screen 2008;13:476-485.

15.

Lingaraj T. , Donovan J. , Li Z. , Li P. , Douchette A. , Harrison S. , et al: A high-throughput liposome substrate assay with automated lipid extraction process for PI3-kinase . J Biomol Screen 2008;13:906-911.

16.

Fuchikama K. , Togame H. , Sagara A. , Satoh T. , Gantner F. , Bacon KB , et al: A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase γ.

17.

Boldyreff B. , Rasmussen TL , Jensen HH , Cloutier A. , Beaudet L. , Roby P. , et al: Expression and purification of pi3 kinase α and development of an ATP depletion and an AlphaScreen PI3 kinase activity assay. J Biomol Screen 2008;13:1036-1040.

18.

Knight ZA , Shokat KM : Features of selective kinase inhibitors. Chem Biol 2005;12:621-637.

19.

Rao VD , Misra S. , Boronenkov IV , Anderson RA , Hurley JH : Structure of type IIβ phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation. Cell 1998;94:829-839.